Public health

CGTN: China monitors coronavirus mutations to adjust COVID-19 response

Retrieved on: 
Sunday, January 1, 2023

Xu said that the country has formulated a work plan to monitor the novel coronavirus variant strains since it optimized COVID-19 prevention and control measures.

Key Points: 
  • Xu said that the country has formulated a work plan to monitor the novel coronavirus variant strains since it optimized COVID-19 prevention and control measures.
  • The National Health Commission (NHC) and China CDC held a video meeting with the WHO, and exchanged views on the current COVID-19 situation, treatment and vaccinations.
  • Technical exchanges would be continued to help end the epidemic worldwide as soon as possible, according to the NHC.
  • China has made efforts to enhance the medical supplies needed, including therapeutic medicines, testing reagents, vaccines, medical masks and protective suits.

CGTN: China monitors coronavirus mutations to adjust COVID-19 response

Retrieved on: 
Sunday, January 1, 2023

Xu said that the country has formulated a work plan to monitor the novel coronavirus variant strains since it optimized COVID-19 prevention and control measures.

Key Points: 
  • Xu said that the country has formulated a work plan to monitor the novel coronavirus variant strains since it optimized COVID-19 prevention and control measures.
  • The National Health Commission (NHC) and China CDC held a video meeting with the WHO, and exchanged views on the current COVID-19 situation, treatment and vaccinations.
  • Technical exchanges would be continued to help end the epidemic worldwide as soon as possible, according to the NHC.
  • China has made efforts to enhance the medical supplies needed, including therapeutic medicines, testing reagents, vaccines, medical masks and protective suits.

Government of Canada announces a temporary negative COVID-19 test requirement for travellers arriving from the People's Republic of China, Hong Kong or Macao

Retrieved on: 
Saturday, December 31, 2022

These planned health measures will apply to air travellers, regardless of nationality and vaccination status.

Key Points: 
  • These planned health measures will apply to air travellers, regardless of nationality and vaccination status.
  • They are temporary measures, in place for 30 days, that will be reassessed as more data and evidence becomes available.
  • Canada remains committed to working with global partners to manage the ongoing COVID-19 response and enhance preparedness for the future.
  • All travellers, regardless of citizenship, are not required to submit public health information through the ArriveCAN app or website.

PG&E Pays Over $339 Million in Property Taxes to 50 California Counties

Retrieved on: 
Wednesday, December 28, 2022

OAKLAND, Calif., Dec. 28, 2022 /PRNewswire/ -- During the second half of 2022, Pacific Gas and Electric Company (PG&E) paid property taxes of over $339 million to the 50 counties where it owns properties that support gas and electric service to 16 million Californians.

Key Points: 
  • OAKLAND, Calif., Dec. 28, 2022 /PRNewswire/ -- During the second half of 2022, Pacific Gas and Electric Company (PG&E) paid property taxes of over $339 million to the 50 counties where it owns properties that support gas and electric service to 16 million Californians.
  • PG&E's payments of more than $339 million covers the period from July 1 to December 31, 2022.
  • This included more than $1 million in relief to communities and small businesses for COVID 19 impacts.
  • PG&E's First Installment of Property Taxes Paid by December 12, 2022

Augusta University Health System, Wellstar Health System announce letter of intent for statewide health care partnership

Retrieved on: 
Tuesday, December 27, 2022

AUGUSTA, Ga., Dec. 27, 2022 /PRNewswire/ -- Augusta University Health System (AUHS) has signed a letter of intent with Wellstar Health System to form an innovative new partnership that would expand Augusta University's educational and research missions and allow Wellstar Health System to create a broader affiliation with the university's Medical College of Georgia (MCG) as AUHS joins the Wellstar Health System.

Key Points: 
  • AUGUSTA, Ga., Dec. 27, 2022 /PRNewswire/ -- Augusta University Health System (AUHS) has signed a letter of intent with Wellstar Health System to form an innovative new partnership that would expand Augusta University's educational and research missions and allow Wellstar Health System to create a broader affiliation with the university's Medical College of Georgia (MCG) as AUHS joins the Wellstar Health System.
  • "AUHS, Augusta University and the Wellstar Health System have a shared mission to solve Georgia's health care challenges," USG Chancellor Sonny Perdue said.
  • "By bringing Augusta University Health System together with Wellstar Health System and leveraging our respective strengths, we would improve the health of the community, address social determinants of health and expand access to quality care for all Georgians," said Candice L. Saunders, FACHE, president and chief executive officer of Wellstar Health System.
  • Keel, PhD, acting chief executive officer of Augusta University Health System and president of Augusta University.

Harm Reduction Therapeutics' New Drug Application for RiVive™ Over-the-Counter Naloxone Nasal Spray Accepted and Granted Priority Review by FDA

Retrieved on: 
Monday, December 26, 2022

PITTSBURGH, Dec. 26, 2022 /PRNewswire/ -- Harm Reduction Therapeutics (HRT), Inc., a 501(c)(3) nonprofit pharmaceutical company whose mission is to prevent opioid overdose deaths by making free or low-cost over-the-counter (OTC) naloxone nasal spray available to the public, today announced that the FDA has accepted its New Drug Application (NDA) for OTC RiVive (3.0 mg intranasal naloxone) for the emergency treatment of opioid overdose. The RiVive NDA was also granted Priority Review, heralding a long-awaited milestone after public health experts1 and the FDA2 called for naloxone to be made available OTC. Harm Reduction Therapeutics expects to hear from the FDA regarding the approval of RiVive by April 28, 2023.

Key Points: 
  • Low-cost, over-the-counter naloxone nasal spray advances to FDA review.
  • The RiVive NDA was also granted Priority Review, heralding a long-awaited milestone after public health experts1 and the FDA2 called for naloxone to be made available OTC.
  • Harm Reduction Therapeutics expects to hear from the FDA regarding the approval of RiVive by April 28, 2023.
  • "When we formed Harm Reduction Therapeutics in 2017, we saw the urgent need to develop an OTC naloxone product, an action that no other company had pursued.

AVMA-championed One Health legislation passes Congress

Retrieved on: 
Friday, December 23, 2022

The legislation passed derives from the AVMA-championed Advancing Emergency Preparedness Through One Health Act that was introduced at the beginning of the 117th Congress.

Key Points: 
  • The legislation passed derives from the AVMA-championed Advancing Emergency Preparedness Through One Health Act that was introduced at the beginning of the 117th Congress.
  • With passage, Congress will now direct federal agencies to develop and submit a national One Health Framework to collaboratively address zoonotic diseases and advance public health preparedness.
  • One Health is the concept that human, animal, and environmental health are all intertwined.
  • By developing a comprehensive federal One Health Framework there will be improved coordination between federal agencies that study human and animal health and the environment.

Soligenix Announces Distribution of Series D Preferred Stock to Holders of its Common Stock

Retrieved on: 
Friday, December 23, 2022

The shares of Series D Preferred Stock will be distributed to such recipients at 5:00 p.m. Eastern Standard Time on January 4, 2023.

Key Points: 
  • The shares of Series D Preferred Stock will be distributed to such recipients at 5:00 p.m. Eastern Standard Time on January 4, 2023.
  • Subject to certain limitations, each outstanding share of Series D Preferred Stock will have 1,000,000 votes per share (or 1,000 votes per one one-thousandth of a share of Series D Preferred Stock).
  • The Series D Preferred Stock will be uncertificated, and no shares of Series D Preferred Stock will be transferable by any holder thereof except in connection with a transfer by such holder of any shares of the Company's common stock held by such holder.
  • In that case, a number of one one-thousandths of a share of Series D Preferred Stock equal to the number of shares of the Company's common stock to be transferred by such holder would be transferred to the transferee of such shares of common stock.

March of Dimes Responds to Congressional Passage of FY 23 Omnibus Spending Bill

Retrieved on: 
Friday, December 23, 2022

ARLINGTON, Va., Dec. 23, 2022 /PRNewswire/ -- March of Dimes, the leading organization fighting for the health of all moms and babies, today responded to Congress passing an omnibus spending bill with key policy and funding priorities to strengthen maternal and infant health, and includes critical new protections for pregnant workers through the Pregnant Workers Fairness Act.

Key Points: 
  • "PWFA was adopted as an amendment to the omnibus thanks to the leadership and determination of its Senate sponsors Senators Bob Casey and Bill Cassidy.
  • "This policy will provide certainty and incentivize more states to take advantage of this coverage option that will save new mothers' lives.
  • March of Dimes policy priorities included in the omnibus spending bill:
    The Pregnant Workers Fairness Act of 2021- Included as part of the omnibus as an amendment on the Senate floor on a 73-24 vote.
  • Jackie Walorski Maternal and Child Home Visiting Program of 2022: Reauthorizes the home visiting program through 2027 and provides $500 million in FY 23; $550 million in FY 24; $600 million in FY 25; $650 million in FY 26; and $800 million in FY 27.

VNA of Central Jersey Expands Access to Vital Community Health Services in Red Bank

Retrieved on: 
Friday, December 23, 2022

RED BANK, N.J., Dec. 23, 2022 /PRNewswire/ -- The Visiting Nurse Association of Central Jersey Community Health Center (VNACJ CHC) and Denholtz Properties is announcing the opening of a new, state-of-the-art community health center in the heart of downtown Red Bank.

Key Points: 
  • New community health center will bring new primary, dental, chiropractic and mental health care services to the west side of Red Bank
    RED BANK, N.J., Dec. 23, 2022 /PRNewswire/ -- The Visiting Nurse Association of Central Jersey Community Health Center (VNACJ CHC) and Denholtz Properties is announcing the opening of a new, state-of-the-art community health center in the heart of downtown Red Bank.
  • It will also afford its clients increased access to high-quality and affordable services, including dental care, as well as expanded primary care services, chiropractic, behavioral and mental health care services.
  • "We are excited for the new opportunities that this larger, more accessible space will present for the Community Health Center," said Christopher Rinn, CEO of the VNA of Central Jersey Community Health Center.
  • "Providing easy, affordable access to quality health care within a community leads to better health outcomes for its residents.